BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Bladder Cancer

1 post
ImmunityBio Announces FDA Acceptance of BLA for N-803 Anktiva Bladder Cancer Drug

Biotech NewsImmunityBio Announces FDA Acceptance of BLA for N-803 Anktiva Bladder Cancer Drug

  • BioTech Health X
  • July 28, 2022
In breaking news, clinical-stage biotechnology company ImmunityBio, Inc. (NASDAQ: IBRX) has announced acceptance by the FDA review of…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • How Phathom Pharmaceuticals (PHAT) Built a Biotech Around One Big Medical Need
  • Why Corvus Pharmaceuticals (CRVS) Is More Than Just Another Biotech Stock
  • From Research Lab to Operating Room: The Rise of Inspire Medical Systems (INSP)
  • Sensei Biotherapeutics (SNSE) Could Become a Hidden Winner in Biotech
  • This Kidney Disease Biotech Is Quietly Targeting a Billion-Dollar Problem — Unicycive Therapeutics (UNCY) Explained
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • January 1, 2026
    How Phathom Pharmaceuticals (PHAT) Built a Biotech Around One Big Medical Need
    • January 1, 2026
    Why Corvus Pharmaceuticals (CRVS) Is More Than Just Another Biotech Stock
    • January 1, 2026
    From Research Lab to Operating Room: The Rise of Inspire Medical Systems (INSP)
    • January 1, 2026
    Sensei Biotherapeutics (SNSE) Could Become a Hidden Winner in Biotech
    • December 31, 2025
    This Kidney Disease Biotech Is Quietly Targeting a Billion-Dollar Problem — Unicycive Therapeutics (UNCY) Explained
Recent Posts
  • The Profitable Biotech No One Is Talking About: Inside Rigel Pharmaceuticals (RIGL)
    • December 31, 2025
  • From Old-School Pharma to Precision Medicine Leader: The Novartis (NVS) Story Is Just Getting Started
    • December 31, 2025
  • From Pain to Pandemics: Why Tonix Pharmaceuticals (TNXP) Is So Unusually Diversified
    • December 31, 2025
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (5)
  • Biotech News (675)
  • Uncategorized (1)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top